Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.96
+0.01000.13%
Volume:22.27K
Turnover:177.76K
Market Cap:54.09M
PE:-0.70
High:8.15
Open:7.94
Low:7.80
Close:7.95
Loading ...

Atara Biotherapeutics Inc - Eric Hyllengren to Step Down as CFO and COO of Atara Biotherapeutics - SEC Filing

THOMSON REUTERS
·
01 Apr

Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement

TIPRANKS
·
11 Mar

Atara Biotherapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
11 Mar

Atara Biotherapeutics (ATRA) Receives a Buy from TD Cowen

TIPRANKS
·
10 Mar

Atara Biotherapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
09 Mar

Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes

TIPRANKS
·
09 Mar

Atara Biotherapeutics Reports 2024 Financial Results

TIPRANKS
·
08 Mar

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
08 Mar

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

Dow Jones
·
08 Mar

Atara Biotherapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
08 Mar

Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year

TIPRANKS
·
08 Mar

Atara Biotherapeutics Q4 2024 GAAP EPS $(1.19) Beats $(3.58) Estimate, Sales $32.753 Miss $19.148M Estimate

Benzinga
·
08 Mar

Atara Biotherapeutics Inc: Strategic Review by Financial Advisor Ongoing

THOMSON REUTERS
·
08 Mar

Atara Biotherapeutics Inc: Implemented a Workforce Reduction of Approximately 50% to Preserve Resources

THOMSON REUTERS
·
08 Mar

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress

Business Wire
·
08 Mar

Atara Biotherapeutics CEO Makes Significant Stock Sale!

TIPRANKS
·
06 Mar

BRIEF-Atara Biotherapeutics Inc To Cut 50% Of Workforce

Reuters
·
04 Mar

Atara Biotherapeutics Inc - Workforce Reduction Expected to Complete by June 2025

THOMSON REUTERS
·
04 Mar

BRIEF-Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Feb

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Feb